We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. All-cause health care costs in adult Medicaid recipients ...

Sogroya is a long-acting form of somatropin. Somatropin is also called human growth hormone. Sogroya is made by attaching human growth hormone to a small protein that helps it stay in the body longer ...

Growth hormone treatment is a safe and effective therapy that’s often used to treat children and adults with a deficiency in human growth hormone (also known as HGH or somatropin). Naturally-occurring ...

A Prescription Drug User Fee Act target date of July 27, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental Biologics License ...

When a child seems much smaller than their classmates or outgrows clothes far more slowly than expected, it can raise ...

Credit: Pfizer. Ngenla is expected to be available in August 2023. The Food and Drug Administration (FDA) has approved Ngenla ™ (somatrogon-ghla), a once-weekly, human growth hormone analog for the ...

Pfizer disclosed the regulatory action late Friday. FDA complete response letters are not public documents, and the company did not say what concerns or questions were raised by the agency about the ...

Children with growth hormone deficiency (GHD) have differences in gut microbiota and microbial metabolites from both individuals with idiopathic short stature (ISS) and healthy controls, suggesting an ...